Chronic Spontaneous Urticaria

The Chronic Spontaneous Urticaria pipeline: 11 tracked drugs, 3 approved for this indication.

Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Chronic Spontaneous Urticaria, so this list is not complete.

3 approved / phase 41 Phase 33 Phase 21 Phase 1/23 preclinical / unstaged

Compare the share prices of listed companies in Chronic Spontaneous Urticaria →

Market size not yet sourced. How markets are sized ↗

The Chronic Spontaneous Urticaria pipeline

← all assets